Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BYGMED3 ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0% 5.0%   Bankruptcy risk   6.6% 6.7% 7.2% 7.4% 6.5% 7.2% 16.5% 16.1%   Credit score (0-100)   37 36 32 32 36 33 11 11   Credit rating   BBB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   296 336 431 451 420 385 0.0 0.0   EBITDA   14.4 29.2 80.1 85.0 71.1 29.9 0.0 0.0   EBIT   14.4 29.2 80.1 85.0 71.1 29.9 0.0 0.0   Pre-tax profit (PTP)   13.3 28.5 79.3 83.1 67.2 30.0 0.0 0.0   Net earnings   10.0 22.4 61.2 64.6 51.8 23.4 0.0 0.0   Pre-tax profit without non-rec. items   13.3 28.5 79.3 83.1 67.2 30.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   186 208 269 276 269 232 96.8 96.8   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   392 349 461 413 467 403 96.8 96.8   Net Debt   -248 -205 -191 -374 -189 -214 -96.8 -96.8     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   296 336 431 451 420 385 0.0 0.0   Gross profit growth   -20.0% 13.7% 28.2% 4.6% -6.9% -8.3% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   392 349 461 413 467 403 97 97   Balance sheet change%   28.4% -11.1% 32.2% -10.4% 13.0% -13.8% -76.0% 0.0%   Added value   14.4 29.2 80.1 85.0 71.1 29.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.9% 8.7% 18.6% 18.8% 16.9% 7.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.1% 7.9% 19.8% 19.4% 16.2% 6.9% 0.0% 0.0%   ROI %   7.3% 14.6% 33.3% 31.1% 25.8% 11.7% 0.0% 0.0%   ROE %   5.2% 11.4% 25.6% 23.7% 19.0% 9.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   47.3% 59.6% 58.4% 66.9% 57.7% 57.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,718.7% -701.0% -238.8% -440.2% -265.4% -716.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.8 2.5 2.3 2.9 2.3 2.2 0.0 0.0   Current Ratio   1.9 2.5 2.4 3.0 2.4 2.4 0.0 0.0   Cash and cash equivalent   247.9 204.9 191.3 374.2 188.6 214.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   187.5 211.9 269.1 277.5 274.4 236.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   14 29 80 85 71 30 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   14 29 80 85 71 30 0 0   EBIT / employee   14 29 80 85 71 30 0 0   Net earnings / employee   10 22 61 65 52 23 0 0